Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants by Khaireh, Bouh Abdi et al.
Plasmodium vivax and Plasmodium falciparum
infections in the Republic of Djibouti: evaluation of
their prevalence and potential determinants
Bouh Abdi Khaireh, Se´bastien Briolant, Aure´lie Pascual, Madjid Mokrane,
Vanessa Machault, Christelle Travaille´, Mohamed Abdi Khaireh, Ismail
Hassan Farah, Habib Moussa Ali, Abdul-Ilah Ahmed Abdi, et al.
To cite this version:
Bouh Abdi Khaireh, Se´bastien Briolant, Aure´lie Pascual, Madjid Mokrane, Vanessa Machault,
et al.. Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti:
evaluation of their prevalence and potential determinants. Malaria Journal, BioMed Central,
2012, 11 (1), pp.395. <10.1186/1475-2875-11-395>. <inserm-00773588>
HAL Id: inserm-00773588
http://www.hal.inserm.fr/inserm-00773588
Submitted on 14 Jan 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
RESEARCH Open Access
Plasmodium vivax and Plasmodium falciparum
infections in the Republic of Djibouti: evaluation
of their prevalence and potential determinants
Bouh Abdi Khaireh1,2,3,4,5†, Sébastien Briolant1,2†, Aurélie Pascual1,2, Madjid Mokrane1,2, Vanessa Machault6,7,
Christelle Travaillé1, Mohamed Abdi Khaireh1,2, Ismail Hassan Farah3, Habib Moussa Ali3, Abdul-Ilah Ahmed Abdi3,
Souleiman Nour Ayeh4, Houssein Youssouf Darar4,8, Lénaïck Ollivier9, Mohamed Killeh Waiss10, Hervé Bogreau1,2,
Christophe Rogier1,2,11 and Bruno Pradines1,2*
Abstract
Background: Formerly known as a hypoendemic malaria country, the Republic of Djibouti declared the goal of
pre-eliminating malaria in 2006. The aim of the present study was to evaluate the prevalence of Plasmodium
falciparum, Plasmodium vivax and mixed infections in the Djiboutian population by using serological tools and to
identify potential determinants of the disease and hotspots of malaria transmission within the country.
Methods: The prevalence of P. falciparum and P. vivax within the districts of the capital city and the rest of the
Republic of Djibouti were assessed using 13 and 2 serological markers, respectively. The relationship between the
immune humeral response to P. falciparum and P. vivax and variables such as age, gender, wealth status, urbanism,
educational level, distance to rivers/lakes, living area, having fever in the last month, and staying in a
malaria-endemic country more than one year was estimated and analysed by questionnaires administered to 1910
Djiboutians. Multivariate ordinal logistic regression models of the immune humeral response were obtained for P.
falciparum and P. vivax.
Results: The P. falciparum and P. vivax seroprevalence rates were 31.5%, CI95% [29.4-33.7] and 17.5%, CI95% [15.8-
19.3], respectively. Protective effects against P. falciparum and P. vivax were female gender, educational level, and
never having visited a malaria-endemic area for more than one year. For P. falciparum only, a protective effect was
observed for not having a fever in the last month, living more than 1.5 km away from lakes and rivers, and younger
ages.
Conclusions: This is the first study that assessed the seroprevalence of P. vivax in the Republic of Djibouti. It is
necessary to improve knowledge of this pathogen in order to create an effective elimination programme. As
supported by recent observations on the subject, the Republic of Djibouti has probably demonstrated a real
decrease in the transmission of P. falciparum in the past seven years, which should encourage authorities to
improve efforts toward elimination.
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Background
According to the World Health Organization (WHO),
approximately 3.3 billion people, nearly half of the world
population, are at risk of malaria. Each year, approxi-
mately 250 million people contract the disease, and
nearly one million people die. The inhabitants of the
poorest countries are the most vulnerable. More than
one in five infant deaths (20%) occurring in Africa are
due to malaria [1]. However, the number of Plasmodium
falciparum malaria cases is declining, even in Africa.
Given this situation, in the late 1990s, WHO proposed a
goal of controlling the disease and achieving elimination
by 2015 in areas of low transmission. Policies, inter-
national and national initiatives have proliferated to help
the neediest.
Based on the results of scientific research in all areas
of malaria control and because of greater knowledge of
the disease and its medical and social consequences, the
proposed strategy is organized into two main phases:
control and disposal [2]. Among the actions undertaken
on a large scale, it should be noted that the availability
and distribution of ITNs and ACT, vector control
through IRS, active detection of new breeding sites and
their systematic destruction represent a link essential to
the success of disease control before disposal is consid-
ered [3].
According to the Roll Back Malaria project, malaria
primarily concerns 109 countries, but 35 countries ac-
count for 98% of malaria deaths worldwide. Only five
of these countries (Nigeria, Democratic Republic of
Congo, Uganda, Ethiopia and Tanzania) represent 50%
of deaths and 47% of malaria cases [4]. Among these
countries, Ethiopia and Uganda share an economic
community, bringing together 340 million people who
are free to move to the Republic of Djibouti [5].
Formerly known to be a malaria meso- to hypoen-
demic country with an unstable malaria transmission
profile [6-8], this country of 818,159 inhabitants declared
a goal of malaria pre-elimination in 2006 [9]. Micro-
epidemics can occur in the presence of favourable set of
conditions, such as unusual rainfall (the last major out-
break occurred in 1999) [10,11]. Over the last 14 years,
the transmission and the malaria cases number
remained low. As a result, foreign armies present in the
Republic of Djibouti have recently considered stopping
their malaria chemoprophylaxis [12], as the French army
did last year.
Djibouti has recently demonstrated its eligibility for
the pre-elimination goal according to technical feasibil-
ity, i.e., the baseline domestic malaria transmission com-
bined with the importation-related transmission and
operational feasibility, which takes into consideration the
country government status, health status and informa-
tion on populations at risk [13]. These observations are
in agreement with parasite genetic diversity studies
[10,11], and one recent work has reported a low trans-
mission level [14].
According to WHO, malaria control requires, at a na-
tional level, the expertise and development of databases
containing information about the parasites found locally
and information about changes in transmission levels
and the status of resistance to anti-malarials [15]. Con-
trol in the short- and medium-term is possible by devel-
oping constantly improved detection and observation
tools and early care and adequate diagnoses in risk
populations [15].
Therefore, serological tools are widely used to assess
the transmission level and thus the prevalence of Plas-
modium falciparum and Plasmodium vivax in human
populations and to assess epidemiological facts of the
past and present [16,17]. One recent work in Somaliland
(the nearest neighbouring country to Djibouti with regu-
lar movements of the population in both directions) has
used serological tools to assess the prevalence of P. fal-
ciparum and P. vivax [18-20].
Starting from this observation, it was necessary to per-
form a similar survey in the Republic of Djibouti. Be-
cause most of the previous studies have primarily
concerned P. falciparum malaria, it was also necessary
to study P. vivax malaria and mixed infections to gather
enough information for elimination [3].
The aim of the present study was to evaluate the
prevalence rate of P. falciparum, P. vivax and mixed
infections in the Djiboutian population by using sero-
logical tools and to identify potential determinants of
hot spots of malaria infection and transmission within
the country.
Methods
Sera samples
The prevalence rate of P. falciparum and P. vivax
infections among adults aged 15–54 years living in the
Republic of Djibouti was estimated using a anonymous
non-correlated cluster sampling method between the
24th and the 31th of March 2002. In brief, 30 clusters
were investigated in the city of Djibouti, and 25 clus-
ters in the other districts of the country. The clusters
were randomly selected proportionally to the popula-
tion size according to the list of quarters used by the
National Direction of Statistics in the city of Djibouti
and the list of the towns used by the expanded
programme of immunization in the other districts. In
each selected site, a starting household was randomly
selected, and the next nearest households were investi-
gated until a total of 44 resident adults per cluster in
the city of Djibouti or 35 resident adults per cluster in
the other districts were obtained. A total of 1,910 blood
samples were collected anonymously in accordance
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with the recommendations of the Djiboutian Ministry
of Health, who gave the ethics clearance for the
present study. Blood samples were stored at 4 °C until
separation of plasma by centrifugation (less than
24 hours after collection) and freezing. Thirty sera
samples from French adults who had never been to
malaria-endemic countries were used as unexposed
negative controls. For the seropositivity threshold, the
means and standard deviations (SDs) of the antibody
intensity of the negative control group for all antigens
were estimated. The lower limit of positivity for each
antibody was taken as the mean + 3 SD of the negative
control group values and corresponded to a mean
fluorescence intensity (MFI) of 1,000. For P. falcip-
arum, a sample was considered to be positive if the re-
activity to at least two different plasmodial antigens
was > 1,000 MFI. For P. vivax, a sample was considered
to be positive if the reactivity to PvMSP1-19 or to
PvMSP1-42 was > 1,000 MFI.
Peptides and proteins
Eleven Peptides (Lsa1-41, Lsa1-J, Lsa3-NR2, Glurp,
GlurpP3, Salsa1, Salsa2, Trap1, Starp-R, CS (NANP)
and SR11.1) were synthesized with an added N-terminal
cysteine residue and covalently coupled with BSA (bo-
vine serum albumin, Sigma-Aldrich, St. Louis, USA) by
Genpep (Ales, France) and stored in aliquots at −20 °C.
P. falciparum merozoite surface protein 1–19 (MSP119)
and apical membrane antigen 1 (AMA1) were obtained
using procedures previously described [14]. For P. vivax,
MSP119 proteins were produced in a baculovirus [21]
and MSP142 as described elsewhere [19].
Bead-based assay
Peptides and proteins were coupled to beads as
described by Ambrosino et al. [22], and an optimal con-
centration of 0.3 nmol was used for each antigen. Fur-
thermore, BSA coated beads were included as a
background control. Ag-coated beads were resuspended
by vortexing and sonication for 5 minutes and were
diluted in equal volumes of PBS and MFIA (Multiplexed
Fluorescence ImmunoAssay) diluent (Charles River La-
boratories Inc, MA, USA) to a final concentration of 80
beads/μl per peptide. The 1.2-μm filter-bottom 96-well
microtiterplates (MSBVS 1210, Millipore, MA, USA)
were rewetted with washing buffer (0.15% Tween 20 in
PBS 7.4) using a vacuum manifold (Millipore). Fifty
microliters of beads and sera (diluted 1:100 in equal
volumes of PBS and MFIA diluents) were added to each
well. Plates were incubated at room temperature in the
dark for 1 h with shaking at 600 rpm. After incubation,
plates were washed eight times with 200 μl of washing
buffer, then 100 μl of the secondary Ab (R-phycoerythrin
F(ab’)2 fragment of goat anti-human IgG, (Interchim,
Montluçon, France), diluted 1:500, was added to each
well. After 30 min of incubation in the dark at room
temperature with shaking, plates were washed as
described previously. Beads were resuspended in 100 μl
of a solution of 5% BSA-PBS, pH 7.4 and analysed on
Luminex system. The system was set to read a minimum
of 100 beads per spectral address, and the results were
expressed as MFI.
Data collection
During the cross-sectional study between the 24th and
the 31th March 2002, self-administered questionnaires
containing several items were filled out by Djiboutian
inhabitants and validated by a member of the research
team. Different types of independent variables were col-
lected: the living area (the city of Djibouti or the rest of
the country), the type of living area (urban or rural),
having stayed in a malaria-endemic country for more
than one year (yes or no), having had a fever during the
last month before the study (yes or no), the utilization of
bed nets (often to always and rarely to never), gender
(male or female), schooling status (schooled or never
schooled), educational level (never schooled, primary
school, secondary school, high school or university),
wealth (poor = less than 65,000 Djiboutian Francs per
home and rich =more than 65,000 Djiboutian Francs
per home), and age.
A Geographic Information System was built in ArcGIS
9.2 (Environmental Research Systems Institute, Red-
lands, CA). The layers were added as follows: i) map of
inland water in Djibouti and the neighbouring countries
(data from Digital Chart of the World, accessed through
DIVA-GIS [23] and ii) 60 points corresponding to the
sampling locations. At every point, the Euclidian dis-
tance to the first pixel of water was computed. This
enabled the creation of a geographical independent
variable, the distance of a cluster to a river or a lake
(≤ 1.5 Km or > 1.5 Km).
Statistical methods
Data were recorded using Excel and were checked
for consistency before statistical analysis using R soft-
ware (version 2.10.1) or STATA software (version 11).
The seropositivity to P. falciparum antigens, P. vivax
antigens or both of them (mixed infection) were ana-
lysed as a dependant variable according to individual
and cluster characteristics using a random effect mixed
logistic regression model. The model was designed to
take into account the intracluster correlations that
could exist due to the sampling design (cluster effect as
random effect). The logistic model was also adjusted
using a generalized estimating equations (GEE) ap-
proach. Random effect and GEE regression models
allow the estimation of cluster-specific and population-
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averaged effects, respectively [24]. First, a descriptive
analysis of the independent variables was performed. A
bivariate analysis was then conducted by entering each
independent variable in a logistic regression model, and
all the results were presented in Additional files 1, 2, 3,
4, 5 and 6. Variables were retained for the multivariate
analysis if their effect had a p-value less than 0.25 [25].
A backward stepwise selection procedure was applied
to retain the significant (p < 0.05) independent variables
and their interactions in the final model. The statistical
quality of the final model was assessed by looking at
the adequacy between observed and predicted preva-
lence rates.
As the immune response to several P. falciparum or
P. vivax antigens could be quantified by MFI, another
ordinal dependant variable in four classes was created:
the level of immune response to P. falciparum antigens
(L0 = seronegativity MFI < 1000, L1 = 1000 ≤MFI < 3800,
L2 = 3800 ≤MFI < 8000, and L3 =MFI ≥ 8000) and P.
vivax antigens (L0 = seronegativity MFI < 1000, L1 =
1000 ≤MFI < 2000, L2 = 2000 ≤MFI < 10000 and L3 =
MFI ≥ 10000). The same type of analysis was applied to
this dependent variable as described above for the sero-
positivity status, using the “svy” command of STATA
(i.e., using the linearized variance estimator based on a
first-order Taylor series linear approximation) to take
into account the cluster effect.
The results of the bivariate Bayesian ordinal multi-
nomial regression analysis are presented in Additional
files 7 and 8.
Results
Plasmodium falciparum seroprevalence
The serological analysis showed that 25.90% of sera
were positive for at least two of the following 11 P. fal-
ciparum peptides: Lsa1-41, Lsa1-J, Lsa3-NR2, Glurp,
GlurpP3, Salsa1, Salsa2, Trap1, Starp-R, CS (NANP) and
SR11.1. The proportion of sera that were positive for
both and at least one of the two recombinant falcip-
arum antigens, i.e., PfMSP1 and PfAMA1, were 13.24%
and 29.98%, respectively. By taking into account the im-
mune humeral response to at least two different pep-
tides or recombinant proteins of the 13 P. falciparum
antigens used in this study, the seropositivity rate to P.
falciparum infection was 31.5% (602/1910 Djiboutian
people), CI95% (29.4-33.7).
Considering the potential determinants of the P. falcip-
arum malaria infection, according to the results of the
multivariate logistic regression analysis (Table 1), some
factors were significantly and independently statistically
associated with a lower risk of being seropositive for
P. falciparum:
– The gender (female gender).
Table 1 Multivariate logistic regression analysis of P. falciparum infection’s seroprevalence
N P % (95%CI) RE
cOR (CI95%) aOR (CI95%) p-value
Gender
Male 742 256 34.5 (31.1-38.0) 1 1 0.0008
Female 1168 346 29.6 (27.0-32.3) 0.78 (0.63-0.96) 0.68 (0.55 - 0.85)
Educational level
No school 1244 448 36.0 (33.3-38.6) 1 1 0.033
Primary 410 106 25.9 (21.7-30.4) 0.65 (0.50-0.84) 0.66(0.50 - 0.87) 1.6x10-5
Secondary, high school or University 256 48 18.8 (14.2-24.1) 0.45 (0.32-0.64) 0.45 (0.31 - 0.64)
Staying in a malaria endemic country more than one year
Yes 167 70 41.9 (34.3-49.8) 1 1 0.0005
No 1743 532 30.5 (28.4-32.7) 0.50 (0.35-0.72) 0.52 (0.36 - 0.75)
Having fever during the last month
Yes 435 175 40.2 (35.6-45.0) 1 1 0.0003
No 1475 427 28.9 (26.8-31.5) 0.61 (0.47-0.78) 0.63 (0.49 - 0.81)
Age (Years)
[15–40] 1360 401 29.5 (27.1-32.0) 1 1 0.0346
[40–55] 550 201 36.5 (32.5-40.7) 1.42 (1.14-1.77) 1.28 (1.02 - 1.61)
Distance to rivers (Km)
> 1.5 Km 1279 364 28.5 (26.0-31.0) 1 1 0.0671
≤ 1.5 Km 631 238 37.7 (33.9-41.6) 1.48 (0.99-2.21) 1.44 (0.97 - 2.14)
N = number; P = seropositivity to P. falciparum; RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
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– The educational level (primary school, secondary
school and higher levels).
– Never having visited a malaria-endemic area for
more than one year.
– Not having had a fever during the last month before
the study.
In contrast, only one risk factor for seropositivity for
P. falciparum was identified: older age (40 years to
55 years). There was a non-significant association of liv-
ing near lakes and rivers (≤ 1.5 Km) with a higher risk of
seropositivity.
Plasmodium vivax seroprevalence
By taking into account the reactivity against PvMSP142
or PvMSP119, the global seropositivity rate to P. vivax
was 17.5% (334/1910 Djiboutian people), CI95% (15.8-
19.3). Considering the potential determinants of the
P. vivax malaria infection, according to the results of
the multivariate logistic regression analysis (Table 2),
some factors were significantly and independently statis-
tically associated with a lower risk of being seropositive
for P. vivax:
– The gender (female gender).
Table 2 Multivariate logistic regression analysis of P. vivax infection’s seroprevalence
N P % (95%CI) RE
cOR (CI95%) aOR (CI95%) p-value
Gender
Male 742 147 19.8 (17.0-22.9) 1 1
Female 1168 187 16.0 (14.0-18.2) 0.75 (0.59-0.97) 0.72 (0.56-0.93) 0.0106
Schooling
Schooled 666 97 14.6 (10.6-15.9) 1 1
Never schooled 1244 237 19.1 (16.9-21.3) 1.32 (1.01-1.73) 1.40 (1.06-1.85) 0.0163
Staying in a malaria endemic
country more than one year
Yes 167 45 26.9 (20.4-34.3) 1 1
No 1743 289 16.6 (14.9-18.4) 0.51 (0.34-0.75) 0.52 (0.35-0.77) 0.0012
N = number; P = seropositivity to P. vivax; RE = Random effect; cOR = Crude odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
Table 3 Multivariate logistic regression analysis of P. falciparum and vivax mixed infection’s seroprevalence
N P % (95%CI) RE
cOR (CI95%) aOR (CI95%) p-value
Type of living area
Rural 553 43 7.8 (5.7-10.3) 1 1 0.0477
Urban 1357 152 11.2 (9.6-13.0) 1.52 (0.83-2.78) 1.77 (1.01 - 3.11)
Gender
Male 742 91 12.3 (10.0-14.8) 1 1 0.0006
Female 1168 104 8.9 (7.3-10.7) 0.65 (0.47-0.90) 0.56 (0.40 - 0.78)
Educational level
Schooled 666 44 6.6 (4.8-8.8) 1 1 0.004
Never Schooled 1244 151 12.1 (10.4-14.1) 1.81 (1.24-2.63) 2.04 (1.38 - 3.02)
Staying in a malaria endemic country more than one year
Yes 167 31 18.6 (13.0-25.3) 1 1 0.0012
No 1743 164 9.4 (8.1-10.9) 0.39 (0.24-0.64) 0.45 (0.27 - 0.73)
Having fever during the last month
Yes 435 65 14.9 (11.7-18.6) 1 1 0.0011
No 1475 130 8.8 (7.4-10.4) 0.54 (0.37-0.77) 0.54 (0.38 - 0.78)
Distance to rivers or lakes (Km)
> 1.5 Km 1210 97 8.0 (6.5-9.7) 1 1 0.0190
≤ 1.5 Km 700 98 14.0 (11.5-16.8) 1.83 (1.07-3.13) 1.83 (1.10 - 3.04)
N = number; P = seropositivity to P. falciparum and P. vivax; RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
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– Never having visited a malaria-endemic country for
more than one year.
Having no schooling was significantly and independ-
ently statistically associated with a higher risk of being
seropositive for P. vivax infection.
Mixed infection seroprevalence
The global seropositivity rate of mixed infection was
10.2% (195/1910 Djiboutian people), CI95% (8.9-11.7).
The results of the multivariate logistic regression ana-
lysis for predicting a mixed infection (Table 3), i.e., sero-
positivity to serological markers of both P. falciparum
and P. vivax, showed that some variables were signifi-
cantly and independently statistically associated with a
lower risk of being seropositive for mixed infection:
– The gender (female gender).
– Never having visited a malaria-endemic country for
more than one year.
– Not having had a fever during the last month before
the study.
Some factors were significantly and independently sta-
tistically associated with a higher risk of being seroposi-
tive for mixed infection:
– The type of living area (urban).
– The educational level (never schooled).
– The distance to rivers or lakes (≤ 1.5 Km).
Bayesian ordinal multinomial logistic regression for the
level of response to P. falciparum antigens
The proportions of P. falciparum seropositives to the dif-
ferent peptides and recombinant proteins from the differ-
ent L-groups (L0 = seronegativity MFI < 1,000, L1 =
1,000 ≤MFI < 3,800, L2 = 3,800 ≤MFI < 8,000, and L3 =
MFI ≥ 8,000) were illustrated in Figure 1. The distribution
of corrected MFI values against the P. falciparum antigens
in the L1, L2 and L3 groups was presented in Figure 2.
According to the results of the Bayesian ordinal multi-
nomial logistic regression analysis (Table 4), some factors
were significantly and independently statistically associated
with a lower risk of having a high level of immune hu-
meral response to P. falciparum antigens:
– The gender (female gender).
– The educational level (primary school, secondary,
high school or university).
– Never having visited a malaria-endemic country for
more than one year.
– Not having had a fever during the last month before
the study.
– Rarely to never used bed nets.
In contrast, only one risk factor was significantly and
independently associated statistically with a risk of hav-
ing a high level of immune humeral response to P. fal-
ciparum antigens:
– The distance to rivers (≤ 1.5 Km).
Figure 1 Proportions of P. falciparum and P. vivax seropositives to the different peptides and recombinant proteins from the different
L-groups (for P. falciparum, L0 = seronegativity MFI < 1000, L1 = 1000 ≤MFI < 3800, L2 = 3800 ≤MFI < 8000, and L3 =MFI ≥ 8000; for P.
vivax, L0 = seronegativity MFI < 1000, L1 = 1000 ≤MFI < 2000, L2 = 2000 ≤MFI < 10000 and L3 =MFI ≥ 10000).
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Bayesian ordinal multinomial logistic regression for the
level of response to P. vivax antigens
The proportions of P. vivax seropositives to the different
recombinant proteins from the different L-groups (L0 =
seronegativity MFI < 1,000, L1 = 1,000 ≤MFI < 2,000, L2
= 2,000 ≤MFI < 10,000 and L3 =MFI ≥ 10,000) were illu-
strated in Figure 1. The distribution of corrected MFI
values against the P. vivax antigens in the L1, L2 and L3
groups was presented in Figure 3. According to the
results of the Bayesian ordinal multinomial logistic re-
gression analysis (Table 5), some factors were signifi-
cantly and independently statistically associated with a
lower risk of having a high level of immune humeral re-
sponse to P. vivax antigens:
– The gender (female gender).
Figure 2 Distribution of corrected MFI values against the P. falciparum antigens in the L1, L2 and L3 groups.
Table 4 Multivariate ordinal logistic regression analysis of serological response to P. falciparum antigens
N P RE
L1 L2 L3 Total cOR (CI95%) aOR (CI95%) p-value
Gender
Male 742 80 79 97 256 1 1 0.0008
Female 1168 116 127 103 346 0.78 (0.65-0.95) 0.66 (0.54-0.81)
Educational level
No school 1244 141 145 162 448 1 1
Primary 410 40 39 27 106 0.61 (0.47-0.77) 0.60 (0.47-0.77)
Secondary, high school or University 256 15 22 11 48 0.41 (0.30-0.57) 0.39 (0.28-0.55)
Staying in a malaria endemic country more than one year
Yes 167 19 18 33 70 1 1 0.0019
No 1743 177 188 167 532 0.57 (0.42-0.78) 0.55 (0.40-0.76)
Having fever during the last month
Yes 435 48 58 69 175 1 1 0.0002
No 1475 148 148 131 427 0.59 (0.47-0.72) 0.59 (0.47-0.73)
Distance to rivers and lakes (Km)
> 1.5 Km 1210 124 121 101 346 1 1 0.0007
≤ 1.5 Km 700 72 85 99 256 1.49 (1.23-1.81) 1.53 (1.25-1.87)
Bed nets utilization
Often to Always 769 82 90 107 279 1 1 0.0007
Rarely to Never 1141 114 116 93 323 0.67 (0.56-0.81) 0.61 (0.50-0.74)
N = number; P = seropositivity to P. falciparum; L = level of intensity of immunological response (seropositivity to P. falciparum antigens) measured in MFI with 3
levels: 1, 2, 3 corresponding respectively to 1000 ≤MFI < 3800, 3800 ≤MFI < 8000, MFI ≥ 8000. The level L0 is not shown here as it’s corresponding to value of MFI
< 1000 considered as negative reaction. RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
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– Never having visited a malaria-endemic country for
more than one year.
– Not having had a fever during the last month before
the study.
Two risk factors were significantly and independently
statistically associated with a risk of having a high level
of immune humeral response to P. vivax antigens:
– The distance to rivers (≤ 1.5 Km).
– The educational level (never schooled).
Geographical repartition
The different clusters of P. falciparum and P. vivax
seroprevalence were presented in Figures 4, 5, 6, and 7
and in Additional file 9. For P. falciparum, the city of
Djibouti showed a clustering of low and medium preva-
lence areas on both sides of the Ambouli wadi. A hot-
spot was observed in Arhiba, in which more than half of
the population (56.4%) (Additional file 10) was seroposi-
tive for P. falciparum. A mean tendency was observed in
the upper town (i.e., Quarters 1 to 15), which globally
showed a decreasing prevalence when the distance to
Figure 3 Distribution of corrected MFI values against the P. vivax antigens in the L1, L2 and L3 groups.
Table 5 Multivariate ordinal logistic regression analysis of the serological response to P. vivax antigens
N P RE
L1 L2 L3 Total cOR (CI95%) aOR (CI95%) p-value
Gender
Male 742 51 52 44 147 1 1 0.0286
Female 1168 54 65 68 187 0.79 (0.62-1.00) 0.74 (0.58-0.94)
Educational level
Schooled 666 37 35 25 97 1 1 0.0168
Non Schooled 1244 68 82 87 237 1.41 (1.09-1.82) 1.44 (1.11-1.87)
Staying in a malaria endemic country more than one year
Yes 167 9 18 18 45 1 1 0.0042
No 1743 96 99 94 289 0.52 (0.37-0.75) 0.53 (0.37-0.76)
Having fever during the last month
Yes 435 25 29 36 90 1 1 0.0447
No 1475 80 88 76 244 0.75 (0.57-0.97) 0.74 (0.56-0.97)
Distance to rivers and lakes (Km)
> 1.5 Km 1210 66 65 60 191 1 1 0.0301
≤ 1.5 Km 700 39 52 52 143 1.39 (1.09-1.76) 1.35 (0.56-0.97)
N = number; P = seropositivity to P. vivax; L = level of intensity of immunological response (seropositivity to P. vivax antigens) measured in MFI with 3 levels: 1, 2, 3
corresponding respectively to 1000 ≤MFI < 2000, 2000 ≤MFI < 10000 and MFI ≥ 10000. The level L0 is not shown here as it’s corresponding to value of MFI < 1000
considered as negative reaction. RE = Random effect; cOR = Crude Odd ratio; aOR = Adjusted Odd ratio; CI95% = Confident interval 95%.
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Ambouli wadi increased. This tendency was also
observed in the lower town, i.e., the other side of the
Ambouli wadi quarter, with 4 hotspots (Balbala 2, PK12,
Balbala 3, and North of Wahle Daba) that had similar
prevalence to Arhiba. The most prevalent cluster in the
entire country was Balbala 4, in which almost two in
three persons (67.5%) were seropositive for P.
falciparum.
In the rest of the country (Additional file 11), the 2
regions in the north (Tadjourah and Obock) exhibited a
low prevalence, except for Balho, in which more than
one in three persons were seropositive for P. falciparum.
The situation in the South was more concerning, as 3
seropositivity hotspots were observed in Dagguirou
(46.9%), Tammiro (64.7%) and As-Eyla (64.7%) in the Re-
gion of Dikhil, and 2 seropositivity hotspots were
observed in Ali-Sabieh1 (52%) and Ali-Sabieh 3 (45.5%),
the capital city of the Region of Ali-Sabieh.
Considering the prevalence of P. vivax, in Djibouti
city, on both sides of Ambouli wadi, an increase in the
Figure 4 Map of clusters of Plasmodium falciparum seroprevalence in the capital of the republic of Djibouti.
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distance between quarters and the wadi was associated
with a decrease in prevalence rates, as was true for P.
falciparum. In the upper town, the only hotspot was in
Arhiba, with a 33.3% seroprevalence. In the lower town,
two hotspots were observed in Balbala 4 and north of
the Wahle Daba, with 35% and 44.4% seroprevalence,
respectively.
Of the northern regions, Obock and Tadjourah, the
seroprevalence rates in some localities were 20% to 30%,
such as in Malâho, La’Assa (Obock Region) and the re-
gional capital Tadjourah (Tadjourah Region). In southern
regions, the seroprevalence rates were between 20% and
30%, such as in Dagguirou, Garabayis (or Gour’abouss)
and As-Eyla for the Dikhil region and Doudoub Balaleh
for the Ali-Sabieh region. Hotspots were observed in
Tammiro, with a 32.4% seroprevalence rate (in the re-
gion of Dikhil), and in Ali-Sabieh 1, with a 40% sero-
prevalence rate (the capital of Ali-Sabieh’s region).
Figure 5 Map of clusters of Plasmodium falciparum seroprevalence in the republic of Djibouti.
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Discussion
The present study was the first to analyse the P. vivax
seroprevalence rate in the Republic of Djibouti. Supple-
mental information on the P. falciparum situation in
2002 was also highlighted.
Serological tools for P. falciparum infection
The use of different antigenic peptides was dictated by
the fact that in countries where malaria transmission
occurs, the results of serology may be ambiguous due to
cross reactions with other parasitic infections, such as
toxoplasmosis [26]. Thus, by increasing the number of
antigens and considering the sera reaction to at least
two different plasmodial antigens, this enabled limiting
the false positive rates. However, this approach using
solely antigenic peptides could lead to an underestima-
tion of the level of transmission; thus, other serologic
markers were included, such as the recombinant pro-
teins MSP1 and AMA1, the use of which there is a con-
sensus in the literature [27-29].
Figure 6 Map of clusters of Plasmodium vivax seroprevalence in the capital of the republic of Djibouti.
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In 2009, Noor et al. observed a P. falciparum sero-
prevalence rate of 14.2% in adults above 50 years, 6.9%
in children and an average of 9.9% when they tested the
reactivity of 4769 sera to one or both serological markers
PfMSP1 and PfAMA1 among Djiboutian population
[14]. The same method was applied to the present work
and produced a seroprevalence rate of 30.0%. Moreover,
when the reaction to at least one marker of the 11 pep-
tides, PfMSP1 and PfAMA1 were combined, the sero-
prevalence increased to 56.6%; finally, a seroprevalence
rate of 33.5% was obtained when considering reactions
to at least 2 of the 13 markers. In light of these observa-
tions, it can be deduced that the prevalence and, indir-
ectly, the P. falciparum malaria transmission have
declined by at least a factor of three in the past seven
years. These results were consistent with the needs and
obligations that lead to a pre-elimination goal in which
the reduction of transmission is the most important key
to pre-elimination [15].
Multivariate logistic regression and Bayesian ordinal
multinomial regression analysis
All obtained models predicting the P. falciparum or P.
vivax seropositivity status or the level of humeral im-
mune response to P. falciparum or P. vivax antigens
have shown that female gender, a high educational level
and never having visited a malaria-endemic country
more than one year were protective. Considering the
mixed infection seropositivity status, the multivariate lo-
gistic regression model showed a protective effect of liv-
ing at a distance > 1.5 Km from rivers and lakes, in a
rural area and not having had fever during the last
month before the cross-sectional study. Only the model
that predicted the P. falciparum seropositivity status
showed a protective effect of younger ages between 15
and 40 years. As serological tools reflect the cumulative
exposition [28], these observations suggest that the older
populations were more exposed and that transmission
was thus higher in the past. In the city of Djibouti, edu-
cational level is generally correlated with the level of
wealth and therefore more accessibility to health facil-
ities and prevention measures [30]. Historically, Ethiopia
and Djibouti have maintained very important population
exchanges in both directions. Therefore, it is normal to
see certain Djiboutian populations settle there for long
periods due to the far lower living costs when facing
economic or social difficulties in the Republic of Dji-
bouti [31]. Carteron in 1978 and Fox in 1991 have
shown that Ethiopia was the most important provider of
malaria cases to Djibouti [7,32]. This may explain the
observation that living in malaria-endemic country (and
especially Ethiopia) for more than one year was a risk
factor for being seropositive to P falciparum or P. vivax.
Geographical distributions of P. falciparum and P. vivax
In the city of Djibouti, the seroprevalence rates for both
parasite species revealed hotspots on both sides of the
main wadi, i.e., Ambouli wadi and the quarters of Arhiba
and Balbala 4. Arhiba and Balbala 4 are quarters with
significant migrant populations who regularly travel to
and/or from Ethiopia [31]. There was an association be-
tween the decreasing of seroprevalent clusters to both
species and the increase of the cluster distance to
Ambouli wadi.
In the rest of the country, P. falciparum seropreva-
lence rates were higher in the southern regions (Dikhil
and Ali-Sabieh), and in particular, hotspots were found
along the land routes to Ethiopia, i.e., Tammiro/As-Eyla
and Ali-Sabieh. These roads are regularly used by profes-
sional truckers, private users and migrants because they
are the only two terrestrial roads to Ethiopia [33].
Plasmodium vivax seropositivity status was more
balanced throughout the Djiboutian territory, with hot-
spots in the same locations in the southern regions as
for P. falciparum. Because of the possibility of liver per-
sistence of hypnozoïtes, P. vivax can spread more widely
across the entire country in the case of incomplete treat-
ment. P. vivax can be found where P. falciparum is no
longer detectable and can sometimes be more prevalent,
as could be the case in the neighbouring countries [34].
This situation might explain the high seroprevalence
rates recorded in northern regions and suggests the oc-
currence of local transmission foci when Anopheles vec-
tors exist.
The path to pre-elimination
Pre-elimination is a combination of technical feasibility,
i.e., the baseline domestic malaria transmission com-
bined with the importation-related transmission, and op-
erational feasibility, which takes into consideration the
country’s government status, health status and informa-
tion on populations at risk [13].
Compared to one recent work [14], the present sero-
logical study indirectly indicates that transmission may
have decreased by three-fold in the past seven years for
P. falciparum, even though some hotspots were the
same as those found in the Dikhil region. This work,
once combined with recent information provided by
Noor et al. has shown that the Republic of Djibouti is
likely on the correct path to pre-elimination with bene-
fits that are threatened by the persistence of hotspots
such as those in the Dikhil Region. Finding the same
hotspots seven years later constitutes a serious threat to
the success of the announced goal. Taking into account
technical and operational feasibility, pre-elimination is
possible only insofar as efficient control methods are
implemented at all administrative and executive levels of
authority.
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Recommendations emerge from the results of the
statistical models. If the educational level of the popu-
lation cannot be increased, pre-elimination will require
increased awareness and health education for at-risk
populations through methods that are appropriate to
local realities. Although being female seems to be
protective, health education should target mothers in
particular to increase local knowledge, as has been pre-
viously done with HIV [35]. Regional collaborative alert
systems are also indispensable because the population
is regularly moving to a neighbouring country. To act
efficiently on hotspots, the mass distribution of bed
nets, mass chemotherapy and chemoprophylaxis for
both parasites and indoor residual spraying should be
performed, followed by serosurveys and vector moni-
toring. The vector monitoring system is actually
debutant and in progress, although it primarily con-
cerns Djibouti city. Border posts should also see an
improvement of their monitoring activities and health
controls.
Figure 7 Map of clusters of Plasmodium vivax seroprevalence in the republic of Djibouti.
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Conclusions
As seen in this study, the P. falciparum seroprevalence
rate was 25.90% in 2002, further studies with the same
population would be required to assess if there was a
real decrease in transmission of P. falciparum in the Re-
public of Djibouti since 2002.
This is the first study that assessed the prevalence of
P. vivax in the Republic of Djibouti. It is necessary to
improve our knowledge of this pathogen in order to cre-
ate an effective elimination programme.
The protective effect of female gender, educational
level and never having visited a malaria-endemic area
for more than one year was observed for both P. falcip-
arum and P. vivax. For P. falciparum along, a protective
effect was also observed for not having had a fever the
last month, living > 1.5 km away from lakes and rivers
and being younger in age.
These findings should encourage authorities to im-
prove efforts toward elimination and to begin the final
assault against the few persistent hotspots. However, to
assess the real pre-elimination status, the precise level of
both P. falciparum and P. vivax transmission should be
regularly monitored by serological methods or other
tools and including children less than five years old.
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